Literature DB >> 15066094

Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan.

Takashi Ohrui, Toshifumi Matsui, Mutsuo Yamaya, Hiroyuki Arai, Satoru Ebihara, Masahiro Maruyama, Hidetada Sasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15066094     DOI： 10.1111/j.1532-5415.2004.52178_7.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  33 in total

1.  Blood pressure and dementia - a comprehensive review.

Authors:  Sean P Kennelly; Brian A Lawlor; Rose Anne Kenny
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial.

Authors:  Whitney Wharton; James H Stein; Claudia Korcarz; Jane Sachs; Sandra R Olson; Henrik Zetterberg; Maritza Dowling; Shuyun Ye; Carey E Gleason; Gail Underbakke; Laura E Jacobson; Sterling C Johnson; Mark A Sager; Sanjay Asthana; Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.

Authors:  Linda Ferrington; Laura E Palmer; Seth Love; Karen J Horsburgh; Paul At Kelly; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2012-04-12       Impact factor: 4.060

4.  Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Linda Ferrington; J Scott Miners; Laura E Palmer; Susan M Bond; Joanne E Povey; Paul At Kelly; Seth Love; Karen J Horsburgh; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2011-02-05       Impact factor: 4.060

5.  Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.

Authors:  Vincenzo Solfrizzi; Emanuele Scafato; Vincenza Frisardi; Davide Seripa; Giancarlo Logroscino; Patrick G Kehoe; Bruno P Imbimbo; Marzia Baldereschi; Gaetano Crepaldi; Antonio Di Carlo; Lucia Galluzzo; Claudia Gandin; Domenico Inzitari; Stefania Maggi; Alberto Pilotto; Francesco Panza
Journal:  Age (Dordr)       Date:  2011-12-28

6.  Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Whitney Wharton; Felicia C Goldstein; Liping Zhao; Kyle Steenland; Allan I Levey; Ihab Hajjar
Journal:  J Am Geriatr Soc       Date:  2015-09       Impact factor: 5.562

7.  The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition.

Authors:  Whitney Wharton; Carey E Gleason; N Maritza Dowling; Cynthia M Carlsson; Eliot A Brinton; M Nanette Santoro; Genevieve Neal-Perry; Hugh Taylor; Frederick Naftolin; Rogerio A Lobo; George Merriam; Joann E Manson; Marcelle I Cedars; Virginia M Miller; Dennis M Black; Matthew Budoff; Howard N Hodis; S Mitchell Harman; Sanjay Asthana
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

9.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

Review 10.  The Role of the Renin-Angiotensin System in Amyloid Metabolism of Alzheimer's Disease.

Authors:  Chao-Liang Chou; Hung-I Yeh
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.